Curalogic is a development company and has gathered a team of specialists in pharmaceuticals development.
Curalogic has no research organisation and is therefore designated as an NRDO company – "No Research, Development Only".
Learn more
Curalogic has initiated a search process to identify new development projects offering an attractive risk profile.
Curalogic expects to conclude an agreement during 2008 that will secure future clinical development projects for the Company.
Major shareholder announcement. Change in shareholding.
Download the announcement (105 kB)
Share capital increase as a result of warrant exercise.
Download the announcement (0,3 MB)